PRME Q1 2025 Earnings — Prime Medicine, Inc. Revenue & Financial Results | Market Cap Arena

PRMEPrime Medicine, Inc.

$771M

Q1 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+146.0% YoY

Gross Profit

$1M100.0% margin

Operating Income

-$52M-3603.3% margin

Net Income

-$52M-3568.8% margin

EPS (Diluted)

$-0.40

QoQ Revenue Growth

-33.4%

Cash Flow

Operating Cash Flow

-$49M

Free Cash Flow

-$51M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$328M

Total Liabilities

$221M

Stockholders' Equity

$107M

Cash & Equivalents

$92M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$591,000	+146.0%
Gross Profit	$1M	-$724,000	+300.8%
Operating Income	-$52M	-$48M	-8.4%
Net Income	-$52M	-$46M	-13.4%

Revenue Segments

Reportable Segment

$1M100%